CURRICULUM VITAE
Yongwoo Seo MD
Yongwoo Seo MD
Assistant Professor
Department of Surgery
Division of Surgery Oncology
Department of Surgery
Division of Surgery Oncology
OFFICE ADDRESS: |
9200 West Wisconsin Avenue |
Milwaukee, WI 53226 |
EDUCATION: |
08/2004 - 06/2008 A.B. in Biology, Harvard University, Cambridge, MA |
08/2010 - 05/2014 M.D. from University of Michigan Medical School, Ann Arbor, MI |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/2014 - 06/2021 Resident, General Surgery, Department of Surgery, University of Washington, 1959 NE Pacific St, Seattle WA, 98195 |
07/2016 - 06/2018 Research Fellow, Fred Hutchinson Cancer Center 1100 Fairview Ave N, Seattle, WA 98109 |
08/2021 - 07/2024 Postdoctoral Fellow, Surgical Oncology, University of Texas MC Anderson Cancer Center |
08/2022 - 07/2023 Education Fellow, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 |
08/2022 - 07/2023 T32 Research Fellow, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 |
FACULTY APPOINTMENTS: |
09/2024 - Present Current, Assistant Professor, The Medical College of Wisconsin, Division of Medicine, Division of Surgical Oncology, 8701 Watertown Plank Rd, Milwaukee, WI 53226 |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
08/2022 - 07/2023 Education Fellow, University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 |
HOSPITAL STAFF PRIVILEGES: |
08/2024 - Present Froedtert Memorial Lutheran Hospital, 9200 W. Wisconsin Ave., Milwaukee, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
American Board of Surgery General Surgery | 10/13/2021 | 01/05/2026 |
Licensure | Number | Issue Date | Expiration |
DEA License | FS0798720 | 02/26/2024 | 02/28/2027 |
Wisconsin License 84562 - | 20 | 08/23/2024 | 10/31/2025 |
AWARDS AND HONORS: |
2011 - Present Global Impact Internship Fellow, William Davidson Institute at the University of Michigan School Business |
2014 - Present Alpha Omega Alpha, University of Michigan Medical School |
2017 - Present Schilling Research Symposium First Place Oral Presentation |
2018 - Present Schilling Research Symposium Second Place Oral Presentation |
2019 - Present Seattle Robotic Surgery Resident Symposium Simulation Competition Winner |
2021 - Present Society of Surgical Oncology Annual Meeting Plenary Session Oral Presenter |
2022 - Present MD Anderson Leading Edge of Cancer Symposium Oral Presentation First Place |
2022 - Present Research Fellowship, Translational Research Incubator for the Treatment |
2023 - Present North American Neuroendocrine Tumor Society Symposium Travel Grant Awardee |
2023 - Present Jesse H. Jones Endowed Fellowship Research Award recipient, MD Anderson Cancer Center |
2024 - Present Clinical Excellence Award winner, MD Anderson Cancer Center Surgical Oncology Fellowship |
2024 - Present Fred Hutch Cancer Center Melanoma Symposium Invited Keynote Speaker |
2024 - Present Eva Lotzóva Translational Research Award winner, MD Anderson Cancer Center |
2025 - Present MCW Cancer Center American Cancer Society Institutional Research Grant recipient, Medical College of Winsconsin |
2025 - Present WeCare Team Impact Award recipient, Medical College of Wisconsin WeCare Fund |
2025 - Present Invited Editor for Special Issue of Cancers titled "Targeted Therapies in Pancreatic Cancer - Current Landscape and Future Directions." Basel, Switzerland |
2025 - Present Digestive Disease Week Shark Tank Innovator Contest, selected as Society of Surgery of the Alimentary Tract representative |
2025 - Present Central Surgical Association Enrichment Award recipient, Medical College of Wisconsin |
Surgical Oncology Fellowship |
University of Washington General Surgery Residency |
University of Washington General Surgery Residency |
Interception, and Prevention of Cancer, MD Anderson Cancer Center |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
2014 - Present Member (American College of Surgeons) |
2016 - Present Member (Society of Surgical Oncology) |
2022 - Present Member (American Society of Clinical Oncology) |
2023 - Present Member (American Association for Cancer Research) |
2024 - Present Member (Society of Asian Academic Surgeons) |
2025 - Present Member (Society for Surgery of the Alimentary Tract) |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
National |
Y. David Seo, Society of Surgical Oncology Annual Meeting Plenary Session Oral Presentation. Dallas, TX, March 2022 |
Y. David Seo, Annual Inter-SPORE Retreat for Melanoma and Skin Cancers at the University of Pittsburgh: Modulation of the gut microbiome to improve response and toxicity to ICB. Pittsburgh, PA, June 2023. |
Y. David Seo, Fred Hutch Cancer Center Northwest Melanoma Symposium, Invited Keynote Speaker: Gut Check: The impact of the microbiome on immune checkpoint blockade response in patients living with melanoma. Seattle, WA, May 2024. |
Y. David Seo, Society of Surgical Oncology Podcast, "Landmark Series - Future of Clinical Trials in Pancreatic Cancer." In press, Boston, MA, June 2025. |
Local |
Y. David Seo, 2025. Medical College of Wisconsin Society for Research Excellence, Invited Speaker: Human Tissue Based Research in Pancreatic Adenocarcinoma: In Silico to Bedside. Milwaukee, WI, April 2025 |
Y. David Seo, Fred Hutchinson Cancer Research Center Program in Immunology Seminar: Intratumoral injection of the toll-like receptor 4 (TLR4) agonist G100 in advanced soft tissue sarcomas. Seattle, WA, October 2017. |
Y. David Seo, University of Washington Research Presentation for Schilling Lecturer Dr. Caprice Greenberg, Second Place Oral Presentation. Seattle, WA, February 2018. |
Y. David Seo, 2024 Sharing Insights on Cancer Care (SHINE) event, Invited Speaker: Pancreatic Cancer, What to Know and Where to Go. Milwaukee, WI, Dec 2024. |
Y. David Seo, 2025. Milwaukee Academy of Surgery meeting, Invited Speaker: AI Driven Integration of Transcriptomic and Clinical Data for Improved Pancreatic Cancer Prognostication. Milwaukee, WI, March 2025. |
Y. David Seo, University of Washington Research Presentation for Schilling Lecturer Dr. Diana Farmer, First Place Oral Presentation. Seattle, WA, February 2017. |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
National |
Y. David Seo, Society of Surgical Oncology Annual Meeting Plenary Session Oral Presentation. Dallas, TX, March 2022 |
Y. David Seo, MD Anderson Cancer Center Leading Edge of Cancer Research Symposium, First Place Oral Presentation. Houston, TX, November 2022. |
Y. David Seo, American Association for Cancer Research Annual Meeting, Advances in Immunotherapy Session, Oral Presentation. San Diego, CA, April 2024 |
Y. David Seo, MD Anderson Cancer Center Research Town Hall, Invited Panel Speaker: Recent High Impact Publications from MD Anderson. Houston, TX, July 2024. |
Y. David Seo, Society of Surgical Oncology Annual Meeting. "Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors." Oral presenter, Boston, MA, March 2023. |
Regional |
Y. David Seo, Western Surgical Association Annual Meeting. "A Contemporary Re-Appraisal of Staging of Fibrolamellar HCC - Examining the Impact of Nodal Status." Santa Barbara, CA, November 2022. |
MCW TEACHING ACTIVITIES: |
Resident and Fellow Education |
- 2024 Jan. 2024 CGSO Fellow Education Lecture Series, "Exocrine Pancreas" |
- 2025 May 2025 MCW Robot Week - Advanced GI Oncology Anastomosis Workshop |
Designed and ran GJ, HJ, PJ workshops for 8 hours |
Continuing Medical Education |
CME event funded by the AHW, full day event with 12 speakers including two invited speakers to educate providers on cutting edge pancreas research |
- 2025 Aug. 2025 MCW Pancreatic Cancer Symposium |
CME event funded by the AHW, full day event including two invited speakers to educate providers on cutting edge pancreas research, as well as connect patients with clinical trials and up-to-date data |
- 2025 Jan. 2025 MCW Pancreatic Cancer Symposium |
Community/Lay Public |
- 2024 Dec. 2024 Sharing Insights on Cancer Care (SHINE) event, Invited Speaker: Pancreatic Cancer, What to Know and Where to Go |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Undergraduate Students |
06/2025 - 08/2025 Natalie Stasny, Summer Research Mentor, Michigan State University |
Medical Students |
11/2024 - Present Jason Yuan, Research Mentor and Current Summer Student Mentor, MCW MS2 |
11/2024 - Present Bahda Yun, Research Mentor and Current Summer Student Mentor, MCW MS2 |
11/2024 - Present Eugene Chen, Research Mentor, MCW MS2 |
11/2024 - Present Imaad Said, Research Mentor, MCW MS2 |
02/2025 - Present Megan Zeller, Research Mentor, MCW MS2 |
05/2025 - Present Alex Eng, Research Mentor, MCW MS2 |
05/2025 - Present Filip Saitis, Research Mentor, MCW MS3 |
Graduate Students |
PhD Committees |
Residents/Fellows |
02/2025 - Present Kshitij Gaur, Research Mentor (CARDS applicant), MCW R3 |
Faculty |
03/2025 - Present Naveen Chandreshekhar PhD, Research Mentor/PI, post-doctoral fellow |
PROGRAMMATIC DEVELOPMENTS: |
Educational Programs |
Resident |
- 2025 May 2025 - Robot Week Surgical Oncology GI Anastomosis Workshop |
Research Programs |
11/2024 - Present TEMPUS Next Generation Sequencing Project, developing pipelines through the MCW Cancer Center Integrated Cancer Data Resource to allow for access to raw genomic and transcriptomic data across all dise |
Community Programs |
- 2024 Dec 2024 - Community SHINE event speaker, Pancreatic Cancer |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Mukherjee S, Raje N, Schoonmaker JA, Liu JC, Hideshima T, Wein MN, Jones DC, Vallet S, Bouxsein ML, Pozzi S, Chhetri S, Seo YD, Aronson JP, Patel C, Fulciniti M, Purton LE, Glimcher LH, Lian JB, Stein G, Anderson KC, Scadden DT. "Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice." Journal of Clinical Investigation. 2008 Feb;118(2):491-504. doi: 10.1172/JCI33102. |
2. Seo YD, Lin J, Chang AC, Orringer MB, Lynch WR, Reddy RM. "Emergent Esophagectomy for Esophageal Perforations: A Safe Option." Annals of Thoracic Surgery. 2015 Sep;100(3):905-9. doi: 10.1016/j.athoracsur.2015.04.055. |
3. Lee KW, Seo YD, Oh SC, Suh SW, Jeong J, Kim H, Yi NJ, Suh KS. "What is the best immunosuppressant combination in terms of antitumor effect in hepatocellular carcinoma?" Hepatology Research. 2016 May;46(6):593-600. doi: 10.1111/hepr.12588. |
4. Sham JG, Richards MK, Seo YD, Pillarisetty VG, Yeung RS, Park JO. "Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?" Journal of Robotic Surgery. 2016 Dec;10(4):307-313. doi: 10.1007/s11701-016-0598-4. |
5. Seo YD, Pillarisetty VG. "T-cell programming in pancreatic adenocarcinoma: a review." Cancer Gene Therapy. 2017 Mar;24(3):106-113. doi: 10.1038/cgt.2016.66. |
6. Jiang X, Seo YD, Chang JH, Coveler A, Nigjeh EN, Pan S, Jalikis F, Yeung RS, Crispe IN, Pillarisetty VG. "Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment." Oncoimmunology. 2017;6(7):e1333210. doi: 10.1080/2162402X.2017.1333210. |
7. Pollack SM, He Q, Yearley JH, Emerson R, Vignali M, Zhang Y, Redman MW, Baker KK, Cooper S, Donahue B, Loggers ET, Cranmer LD, Spraker MB, Seo YD, Pillarisetty VG, Ricciotti RW, Hoch BL, McClanahan TK, Murphy E, Blumenschein WM, Townson SM, Benzeno S, Riddell SR, Jones RL. "T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas." Cancer. 2017 Sep 1;123(17):3291-3304. doi: 10.1002/cncr.30726. |
8. Thornblade LW, Seo YD, Kwan T, Cardoso JH, Pan E, Dembo G, Yeung RSW, Park JO. "Enhanced Recovery via Peripheral Nerve Block for Open Hepatectomy." Journal of Gastrointestinal Surgery. 2018 Jun;22(6):981-988. doi: 10.1007/s11605-017-3656-y. |
9. Jiang X, Seo YD, Sullivan KM, Pillarisetty VG. "Establishment of Slice Cultures as a Tool to Study the Cancer Immune Microenvironment." Methods in Molecular Biology. 2019;1884:283-295. doi: 10.1007/978-1-4939-8885-3_20. |
10. Seo YD, Jiang X, Sullivan KM, Jalikis FG, Smythe KS, Abbasi A, Vignali M, Park JO, Daniel SK, Pollack SM, Kim TS, Yeung R, Crispe IN, Pierce RH, Robins H, Pillarisetty VG. "Mobilization of CD8+ T Cells via CXCR4 Blockade Facilitates PD-1 Checkpoint Therapy in Human Pancreatic Cancer." Clinical Cancer Research. 2019 Jul 1;25(13):3934-3945. doi: 10.1158/1078-0432.CCR-19-0081. |
11. Ludwig AD, Labadie KP, Seo YD, Hamlin DK, Nguyen HM, Mahadev VM, Yeung RS, Wilbur DS, Park JO. "Yttrium-90-Labeled Anti-Glypican 3 Radioimmunotherapy Halts Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma." Journal of Oncology. 2019 Sept 15. doi: 10.1155/2019/4564707. |
12. Kenerson HL, Sullivan KM*, Seo YD*, Stadeli KM, Ussakli C, Pilarisetty VG, Park JO, Riehle KJ, Yet M, Tian Q, Yeung RS. "Tumor Slice Culture as a Biologic Surrogate of Human Cancer." Annals of Translational Medicine. 2020 Feb;8(4). doi: 10.21037/atm.2019.12.88. |
13. Daniel SK, Seo YD, Pillarisetty VG. "The CXCL12-CXCR4/CXCR7 axis as a mechanism of immune resistance in gastrointestinal malignancies." Seminars in Cancer Biology. 2020 Oct;65:176-188. doi: 10.1016/j.semcancer.2019.12.007. |
14. Labadie KP, Droullard DJ, Lois AW, Daniel SK, McNevin KE, Gonzalez JV, Seo YD, Sullivan KM, Bilodeau KS, Dickerson LK, Utria AF, Calhoun J, Pillarisetty VG, Sham JG, Yeung RS, Park JO. IWATE criteria are associated with perioperative outcomes in robotic hepatectomy: a retrospective review of 225 resections. Surgical Endoscopy. 2022;36(2):889-895. doi:10.1007/s00464-021-08345-w |
15. Goff PH, Riolobos L, LaFleur BJ, Spraker MB, Seo YD, Smythe KS, Campbell JS, Pierce RH, Zhang Y, He Q, Kim EY, Schaub SK, Kane GM, Mantilla JG, Chen EY, Ricciotti R, Thompson MJ, Cranmer LD, Wagner MJ, Loggers ET, Jones RL, Murphy E, Blumenschein WM, McClanahan TK, Earls J, Flanagan KC, LaFranzo NA, Kim TS, Pollack SM. Neoadjuvant therapy induces a potent immune response to sarcoma, dominated by myeloid and B cells. Clinical Cancer Research. 2022;28(8):1701-1711. |
16. Sullivan KM, Jiang X, Guha P, Lausted C, Carter JA, Hsu C, Labadie KP, Kohli K, Kenerson HL, Daniel SK, Yan X, Meng C, Abbasi A, Chan M, Seo YD, Park JO, Crispe IN, Yeung RS, Kim TS, Gujural TS, Tian Q, Katz SC, Pillarisetty VG. Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. Gut. 2023;72(2):325-337. doi:10.1136/gutjnl-2021-325808 |
17. Ikoma N, Seo YD, Newhook TE, Maxwell JE, Kim MP, Tran Cao HS, Tzeng CWD, Chun YS, Lee JE, Vauthey JN, Katz MHG. Quality of superior mesenteric and hepatic artery dissection in robotic pancreatoduodenectomy for pancreatic cancer. Journal of Hepatobiliary Pancreatic Sciences. 2023;30(1):e1-e2. doi:10.1002/jhbp.1218 |
18. Seo YD, Katz MHG. Preoperative therapy for pancreatic adenocarcinoma--precision beyond anatomy. Cancer. 2022;128(16):3041-3056. doi:10.1002/cncr.34273 |
19. Knisely A, Seo YD, Wargo JA, Chelvanambi M. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers. 2023;15(3):777. doi:10.3390/cancers15030777 |
20. Cass SH, Tobin JWD, Seo YD, Gener-Ricos G, Keung EZ, Burton EM, Davies MA, McQuade J, Lazar AJ, Mason R, Millward M, Warburton L, Sandhu S, Khoo C, Guerra V, Haydon A, Long GV, Carlino M, Smith JL, Dearden H, Mollee P, Burgess M, Mapp S, Keane C, Atkinson V, Parikh S, Markovic SN, Ding W, Call TG, Hampel PJ, Wargo JA, Ferrajoli A. Efficacy of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma in Patients with Concomitant Chronic Lymphocytic Leukemia. Annals of Oncology, Published online July 4, 2023:S0923-7534(23)00735-4. doi:10.1016/j.annonc.2023.06.007. |
21. Zhang X, Irajizad E, Hoffman KL, Fahrmann JF, Li F, Seo YD, Browman GJ, Dennison JB, Vykoukal J, Luna PN, Siu W, Wu R, Murage E, Ajami NJ, McQuade JL, Wargo JA, Long JP, Do KA, Lampe JW, Basen-Engquist KM, Okhuysen PC, Kopetz S, Hanash SM, Petrosino JF, Scheet P, Daniel CR. Modulating a prebiotic food source influences inflammation and immune-regulating gut microbes and metabolites: insights from the BE GONE trial. EBioMedicine. 2023 Nov 20;:104873. doi: 10.1016/j.ebiom.2023.104873. |
22. Seo YD, Lu H, Black G, Smythe K, Yu Y, Hsu C, Ng J, Hermida de Viveiros P, Warren EH, Schroeder BA, O'Malley RB, Cranmer LD, Loggers ET, Wagner MJ, Bonham L, Pillarisetty VG, Kane G, Berglund P, Hsu FJ, Mi X, Alexiev BA, Pierce RH, Riddell SR, Jones RL, Ter Meulen J, Kim EY, Pollack SM. Toll-Like Receptor 4 Agonist Injection With Concurrent Radiotherapy in Patients With Metastatic Soft Tissue Sarcoma: A Phase 1 Nonrandomized Controlled Trial. JAMA Oncology. 2023 Dec 1;9(12):1660-1668. doi: 10.1001/jamaoncol.2023.4015. |
23. Pothuri VS, Hogg GD, Conant L, Borcherding N, James CA, Mudd J, Williams G, Seo YD, Hawkins WG, Pillarisetty VG, DeNardo DG, Fields RC. Intratumoral T-cell receptor repertoire composition predicts overall survival in patients with pancreatic ductal adenocarcinoma. Oncoimmunology. 2024;13(1):2320411. doi: 10.1080/2162402X.2024.2320411. |
24. Seo YD*, Glitza IC*, Spencer CN, Wortman JR, Burton EM, Alayli FA, Loo CP, Gautam S, Damania A, Densmore J, Fairchild J, Cabanski CR, Wong MC, Peterson CB, Weiner B, Hicks N, Aunins J, McChalicher C, Walsh E, Tetzlaff MT, Hamid O, Ott PA, Boland GM, Sullivan RJ, Grossmann KF, Ajami NJ, LaVallee T, Henn MR, Tawbi HA, Wargo JA. Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity. Cancer Discovery. 2024 Jul 1;14(7):1161-1175. doi: 10.1158/2159-8290.CD-24-0066. (*authors contributed equally) |
25. Fields BC, Ayabe RI, Seo YD, Maxwell JE, Halperin DM. Current Status of Immunotherapy in Management of Small Bowel Neuroendocrine Tumors. Curr Oncol Rep. 2024 Nov;26(11):1530-1542. doi: 10.1007/s11912-024-01610-w. Epub 2024 Oct 28. Review. |
26. Bhutiani N, Seo YD, Robinson KA, White MG, Ikoma N, Mansfield PF, Li JJ, Murphy MB, Ajani JA, Badgwell BD. HIPEC for metastatic gastric cancer: Moving the needle towards 3-year survival. Eur J Surg Oncol. 2025 Jan;51(1):108790. doi: 10.1016/j.ejso.2024.108790. Epub 2024 Oct 25. |
27. Seo YD, Acidi B, Newton A, Haddad A, Chiang YJ, Coelho R, Newhook TE, Tzeng CD, Chun YS, Ludmir EB, Koay EJ, Javle M, Vauthey JN, Cao HST. Defining the Role of Adjuvant Radiotherapy for Biliary Tract Cancers: A Site-Specific Propensity-Matched Analysis. Cancers (Basel). 2025 Feb 2;17(3). doi: 10.3390/cancers17030494. |
28. Seo YD, Katz MHG, Snyder RA. The Landmark Series: The Future of Pancreatic Cancer Clinical Trials. Ann Surg Oncol. 2025 Apr;32(4):2777-2785. doi: 10.1245/s10434-024-16840-2. |
29. Seo YD*, Ayabe RI*, Melendez B, Fields BC, Diggs L, Lazcano R, Wani K, Ingram D, Johnson S, Chelvanambi M, Hudgens C, Hernandez S, Ajami NJ, Wargo JA, Lazar AJ, Knafl M, Woodman S, Halperin DM, Estrella JS, Maxwell JE. Cancer Testis Antigen Expression Correlates with Immune Activation and Prolonged Survival in Small Bowel Neuroendocrine Tumors. In press, JCO Precision Oncology, April 2025 (*authors contributed equally). |
30. Publications under review |
31. Thakkar K, Corentin R, Fu H, Simpson B, Cha H, Coulton A, Augustine M, Veeriah S, Castro A, AbdulJabbar K, Zhang H, Moore D, Sivakumar M, Hardas A, Huebner A, Al-Bakir M, Karasaki T, Pich O, Bailey C, Hill M, Frankell A, Ward S, Naceur-Lombardelli C, Akarca A, Marafioti T, Damania A, Chelvanambi M, Ajami N, Seo YD, Al-Sawaf O, McGranahan N, Jamal-Hanjani M, Wargo JA, Santini J, Swanton C, Litchfield K. Cancer associated bacteria in primary and metastatic lung cancer in TRACERx. Under review at Cell Press, May 2024. |
32. Park EM, Seo YD, Medik YB, Schneider SM, Soto RA, Damania AV, Melendez B, Johnson SB, Singh BB, Wani K, Ingram DR, Wong MC, Bhutiani N, Campbell E, Cass S, Miao Q, Shen L, Minowa T, Shavkunov A, Lazcano R, Zhou Y, Babcock RL, Dyevoich AM, Kahn LM, Patel B, Pineda JE, Halsey T, Witt RG, Ayabe RI, White MG, Peterson CB, Baruch EN, Wang J, Chen K, Gubin MM, Jenq RR, Subbiah V, Ajami NJ, Wargo JA, Watowich SS. Metronidazole alters gut microbes and improves cancer immunotherapy results. Under review at Nature, June 2024. |
33. Verhagen CT, Westerman G, Heaviland H, Lynch E, Brandenburg O, Adams-Patton J, Schwind R, Seo YD, Clarke CN, George B, Kothari AN. Understanding Unrealized Trial Enrollments Following Patient-to-Trial Matching. Under review at Surgery, May 2025. |
Books, Chapters, and Reviews |
1. Seo YD, Crispe IN, Pillarisetty VG. "Chapter 10: Fundamentals of liver and pancreas immunology." Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 7th edition. Elsevier, October 2022. |
Editorials, Letters To Editor, Other |
1. Seo YD, Wargo JA. From bugs to drugs: Bacterial 3-IAA enhances efficacy of chemotherapy in pancreatic cancer. Cell Reports Medicine. 2023 May 16;4(5):101039. |
2. Seo YD, Ajami NA, Wargo JA. Using gut microbes to treat cancer. Nature Medicine. Published online July 7, 2023. doi:10.1038/s41591-023-02460-y. |
3. Seo YD, Pollack SM. Local Immunoradiotherapy in Patients With Metastatic Soft-Tissue Sarcoma - Reply. JAMA Oncology. 2024 Apr 11;. doi: 10.1001/jamaoncol.2024.0311. |
Non-Refereed Journal Publications/Original Papers |
1. Kothari AN, Thalji SZ, Aldakkak M, SenthilKumar G, Belbahri M, Shaik T, Jaraczewski T, Merrill J, Ramamurthi A, Banerjee A, Taylor B, Kamgar B, George B, Erickson B, Hall W, Lytle N, Seo YD, Christians KK, Clarke CN, Evans DE, Tsai S. AI-Derived Electronic Tumor Marker (e19-9) Can Measure Treatment Response and Outcomes in CA19-9 Non-Producers with Pancreatic Ductal Adenocarcinoma. Preprint, available at Research Square, doi:10.21203/rs.3.rs-5738775/v1. |
Abstracts |
1. Reagan K, Seo YD, Churchman E, Kiwango J, Gervas S, Whiddon L. "Monthly Monitoring at a Small NGO: Mobile Phones vs Paper." Oral presentation, XIX International AIDS Conference, Washington DC, July 2012. |
2. Sham JG, Richards MK, Seo YD, Pillarisetty VG, Yeung RS, Park JO. "Efficacy and cost of robotic hepatectomy: is the robot cost-prohibitive?" Oral presenter, American College of Surgeons WA-OR Chapter Annual Meeting, June 2015. |
3. Seo YD, Jalikis F, Jiang X, Vignali M, Robins H, Pillarisetty VG. "T-Cell Receptor Immunosequencing Reveals Novel Insights into the Immune Response to Human Pancreatic Cancer." Poster presentation, Society of Surgical Oncology Annual Cancer Symposium. Seattle, WA, March 2017. |
4. Jiang X, Seo YD, Chang JH, Coveler A, Nigjeh EN, Pan S, Jalikis F, Yeung RS. "Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment." Poster presentation, American Association for Cancer Research Annual Meeting. Washington DC, April 2017. |
5. Seo YD, Kim EY, Conrad III EU, O'Malley RB, Cooper S, Donahue B, Cranmer L, Lu H, Hsu FJ, Loggers E, Hain T, Davidson D, Bonham L, Pillarisetty VG, Kane G, Riddell SR, Jones RL, Pollack SM. "Intratumoral Injection of the Toll-Like Receptor 4 (TLR4) Agonist G100 Induces a T-Cell Response in the Soft Tissue Sarcoma Microenvironment." Poster presentation, American Association for Cancer Research Annual Meeting. Washington DC, April 2017. |
6. Seo YD, Sullivan KM, Park JO. "Robotic Transduodenal Resection of an Ampullary Neuroendocrine Tumor." Oral presenter, Society for Surgery of the Alimentary Tract Annual Meeting at Digestive Disease Week. Chicago, IL, May 2017. |
7. Ludwig AD, Seo YD, Hamlin DK, Nguyen HM, Yeh MM, Yeung RS, Wilbur DS, Park JO. "Yttrium-90-Labeled Anti-Glypican-3 Antibody Reduces Tumor Growth in an Orthotopic Xenograft Model of Hepatocellular Carcinoma." Poster presentation, Society for Surgery of the Alimentary Tract Annual Meeting at Digestive Disease Week. Chicago, IL, May 2017. |
8. Seo YD, Kim EY, Conrad III EU, O'Malley RB, Cooper S, Donahue B, Cranmer L, Lu H, Hsu FJ, Loggers E, Hain T, Davidson D, Bonham L, Pillarisetty VG, Kane G, Riddell SR, Jones RL, Pollack SM. "Intratumoral Injection of the Toll-Like Receptor 4 (TLR4) Agonist G100 Induces a T-Cell Response in the Soft Tissue Sarcoma Microenvironment." Poster presentation, Connective Tissue Oncology Society Annual Meeting. Maui, HI, November 2017. |
9. Seo YD, Zhou J, Morse K, Patino J, Mackay S, Kim EY, Conrad III EU, O'Malley RB, Cooper S, Donahue B, Cranmer L, Lu H, Hsu FJ, Loggers E, Hain T, Davidson D, Bonham L, Pillarisetty VG, Kane G, Riddell SR, Jones RL, Pollack SM. "Intratumoral (IT) Injection of the Toll-Like Receptor 4 (TLR4) Agonist G100 Induces a Clinical Response and a T Cell Response Locally and Systemically." Poster presentation, ASCO-SITC Clinical Immuno-Oncology Symposium. San Francisco, CA, January 2018. |
10. Seo YD, Jalikis F, Jiang X, Sullivan KM, Vignali M, Robins H and Pillarisetty VG. "Combination T-Cell Receptor Immunosequencing and Multiplex Immunohistochemistry Reveal Novel Insights into the Immune Response to Human Pancreatic Cancer." Poster presentation, American Association for Cancer Research Annual Meeting. Chicago, IL, April 2018. |
11. Sullivan KM, Seo YD, Jiang X, Kim TS, Yeung RS, Pillarisetty VG. "PDA Tumor Cell Death as Following Combination Anti-PD-1 Blockade and CXCR4 Blockade is a Direct Effect of CD8+ T-cells." Poster presentation, Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference. New York, NY, October 2018. |
12. Kim TS, Spraker M, Seo YD, Smythe K, Pierce R, Hain T, Kim EY, Kane G, Jenkins I, He Q, Pollack SM. "Neoadjuvant Therapy Induces a Potent Inflammatory and Corresponding Regulatory Response Within the Sarcoma Immune Microenvironment." Poster presentation, Connective Tissue Oncology Society Annual Meeting. Rome, Italy, November 2018. |
13. Kim TS, Jiang X, Seo YD, Sullivan KM, Kenerson H, Yeung RS, Pillarisetty VG. "Tumor Slice Culture Represents a Unique Model In Which to Interrogate the Immune Response to Human Soft Tissue Sarcoma." Poster presentation, Connective Tissue Oncology Society Annual Meeting. Rome, Italy, November 2018. |
14. Jiang X, Sullivan KM, Labadie KP, Daniel SK, Seo YD, Abbasi A, Kim TS, Yeung RS, Pillarisetty, VG. "Combination Immunotherapy with PD-1 and CXCR4 Blockade Activates Antitumor Immunity Against Pancreatic Neuroendocrine Tumors." Poster presentation, American Association for Cancer Research Annual Meeting. Atlanta, GA, April 2019. |
15. Mackay S, Chen J, Patino J, Seo YD, Pollack S, Zhou J. "Single-cell polyfunctionality of circulating CD4+ T cells correlates with T cell receptor repertoire diversity of PBMCs, indicating potential synergistic activity and peripheral biomarker predictive of efficacy of intratumor injection of the toll-like receptor 4 agonist G100." Poster presentation, American Association for Cancer Research Annual Meeting. Atlanta, GA, April 2019. |
16. Seo YD, Lu H, Black G, Smythe K, Hsu C, Xu Y, Warren E, Ng J, Conrad E, Cranmer L, Loggers E. "Intratumoral Injection of the Toll-like Receptor 4 Agonist G100 Induces Durable Local Control and Causes Immune Activation in the Tumor Microenvironment in Metastatic Soft Tissue Sarcomas." Plenary Session Oral Presenter, Society of Surgical Oncology Annual Meeting. Dallas, TX, March 2022. |
17. Seo YD, Concors SJ, Chun YS, Newhook TE, Tzeng CWD, Vauthey JN, Tran Cao HS. "A Contemporary Re-Appraisal of Staging of Fibrolamellar HCC - Examining the Impact of Nodal Status." Oral presenter, Wester Surgical Association Annual Meeting. Santa Barbara, CA, November 2022. |
18. Seo YD, Bhutiani N, Wong MC, Damania A, Morad G, Lastrapes M, Lazar AJ, Wargo JA, Ajami NJ. "VirMAP for Cancer: Characterization of the intratumoral virome in virally-associated cancers and a resource for investigators." Poster presentation, Society of Immunotherapy of Cancer, Spring Scientific Meeting. Denver, CO, March 2023. |
19. Park E, Medik YB, Seo YD, Damania A, Mishra A, Campbell E, Zhou Y, Kahn LM, Patel B, Amaji NJ, Subbiah V, Wargo JA, Watowich SS. Treatment with metronidazole improves response and reduces toxicity to treatment with immune checkpoint blockade. Oral presentation, Society of Immunotherapy of Cancer, Spring Scientific Meeting. Denver, CO, March 2023. |
20. Seo YD, Witt RG, Cass SH, Lazcano R, Hudgens C, Wani K, Hernandez SD, Halperin DM, Lazar AJ, Wargo JA, Estrella JS, Maxwell JE. Cancer testis antigen and interleukin expression correlates with survival in small bowel neuroendocrine tumors. Oral presenter, Society of Surgical Oncology Annual Meeting. Boston, MA, March 2023. |
21. Seo YD, Bhutiani N, Wong MC, Damania A, Morad G, Lastrapes M, Lazar AJ, Wargo JA, Ajami NJ. "VirMAP for Cancer: Characterization of the intratumoral virome in virally-associated cancers and a resource for investigators." Poster presentation, American Society of Clinical Oncology, Annual Meeting. Chicago, IL, June 2023. |
22. Seo YD, Ayabe RI, Fields BC, Melendez B, Lazcano R, Wani K, Johnson S, Witt RG, Cass S, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, WArgo JA, Lazar AJ, Halperin DM, Estrella JS, Maxwell JE. "Cancer Testis Antigen Expression Correlates with Type-I Interferon Signaling and Improved Prognosis in Small Bowel Neuroendocrine Tumors." Oral poster presentation, North American Neuroendocrine Tumor Society Annual Symposium, Montreal, Quebec, Canada, October 2023. |
23. Ayabe RI, Seo YD, Melendez B, Lazcano Segura R, Fields BC, Wani KM, Johnson S, Witt R, Chelvanambi M, Hudgens C, Hernandez SD, Ajami NJ, Wargo JA, Lazar AJ, Halperin DM, Estrella J, Maxwell J. Correlation of cancer testis antigen expression with high type-I interferon signal and prognosis in small bowel neuroendocrine tumors. Poster presentation, American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, January 2024. |
24. Fernandez E, Cass S, Seo YD, Damania AV, Meng X, Sahasrabhojane PV, Liu JS, Liu W, Chen Y, Bassett RL, Shelburne S, Chiang HY, Somaiya KR, Mungovan KS, Malke JC, Matejka B, Fisher SB, Lucci A, Lee JE, Ross MI, Gershenwald JE, Sharma P, Ajami NJ, Roland CL, Wargo JA, Keung EZ. A single dose of perioperative cefazolin disrupts the gut microbiome and immunity in patients (pts) with early-stage melanoma. Poster presentation, American Association of Cancer Research Annual Meeting, San Diego, CA, April 2024. |
25. Seo YD*, Glitza Oliva IC*, Spencer CN*, Wortman JR*, Burton EM, Alayli FA, Loo C, Gautam S, Damania AV, Densmore J, Fairchild J, Cabanski C, Wong MC, Peterson CB, Weiner B, Hicks N, Aunins J, McChalicher C, Tetzlaff MT, Hamid O, Ott PA, Boland GM, Sullivan RJ, Grossman KF, Ajami NJ, LaVallee TM, Henn MR, Tawbi HA, Wargo JA. "Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation in melanoma: Impact of antibiotic pre-conditioning on microbiome and immunity." Oral presenter, Late Breaking and Clinical Trials, Advances in Immunotherapy Session. American Association for Cancer Research Annual Meeting, San Diego, CA, April 2024. |
26. Ying G, Auckley E, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DE, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M. MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12D or KRAS G12V alteration. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, January 2025. |
27. Ying G, Yohay S, Aldakkak M, Thalji SZ, Vakili P, Grahl J, Mayer B, Shahjehan F, Low SK, Evans DE, Christians KK, Seo YD, Erickson B, Hall WA, McFall T, Kurzrock R, George B, Kamgar M. MEK inhibitor-based therapy in metastatic pancreatic adenocarcinoma with KRAS G12R alteration. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, January 2025. |
28. Low SK, Thalji SZ, Aldakkak M, Ying G, Yohay S, Auckely E, Vakili P, Shahjehan F, Evans DE, Christians KK, Seo YD, Erickson B, Small-Tom CJ, Heyer V, Neupane B, George B, Kothari AN, Hall WA, Kamgar M. Impact of Neoadjuvant Radiation Therapy Modalities on Post-Surgical Lymphopenia in Operable Pancreatic Cancer. American Society of Clinical Oncology Gastrointestinal Cancers Symposium, San Francisco, CA, January 2025. |
29. Aldakkak M, Kamgar M, George B, Phan AT, Dua K, Christians KK, Seo YD, Kothari A, Lee W, Kerstin K, Maduekwe U, Nataliansyah MM, Erickson B, Hall WA, Evans DE, Clarke CN. Effect of enrollment in a clinical trial on treatment outcomes of patients with pancreas cancer. American Society of Clinical Oncology Annual Meeting, Chicago, IL, May 2025. |
30. Verhagen CT, Westerman G, Heaviland H, Lynch E, Brandenburg O, Adams-Patton J, Schwind R, Seo YD, Clarke CN, George B, Kothari AN. Understanding Unrealized Trial Enrollments Following Patient-to-Trial Matching with OncoLLM in Surgical Oncology. Oral presentation, Central Surgical Association Annual Meeting, Indianapolis, IN, June 2025. |
31. SenthilKumar G, Aldakkak M, Hall WA, Erickson BA, Kamgar M, George B, Clarke C, Kothari A, Christians KK, Evans DB, Seo YD. The Impact of Surgery on Overall Survival Among Patients with Locally Advanced Pancreatic Adenocarcinoma. Oral Presentation, Central Surgical Association Annual Meeting, Indianapolis, IN, June 2025. |
